Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 8 | 11 | 13 | 65 |
| Receivables | 36 | 49 | 53 | 33 | 22 |
| Inventories | 174 | 180 | 144 | 173 | 177 |
| Other current assets | 0 | 11 | 0 | 15 | 15 |
| TOTAL | $258 | $260 | $223 | $295 | $317 |
| Non-Current Assets | |||||
| PPE Net | 32 | 36 | 40 | 43 | 43 |
| Intangibles | 115 | 109 | 91 | 89 | 81 |
| Other Non-Current Assets | 0 | 0 | 0 | 1 | 1 |
| TOTAL | $147 | $145 | $130 | $133 | $125 |
| Total Assets | $405 | $405 | $353 | $428 | $443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 332 | 291 | 256 | 195 | 184 |
| TOTAL | $600 | $775 | $669 | $659 | $551 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 65 | 0 | 0 | 37 | 197 |
| TOTAL | $65 | $N/A | $N/A | $37 | $197 |
| Total Liabilities | $665 | $775 | $669 | $696 | $748 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,134 | 61,977 | 61,977 | 61,362 | 61,362 |
| Common Shares | 7 | 62 | 62 | 61 | 58 |
| Retained earnings | -4,042 | -3,408 | -3,207 | -2,996 | -2,313 |
| Other shareholders' equity | -497 | -5 | -7 | 42 | -10 |
| TOTAL | $-260 | $-369 | $-316 | $-267 | $-305 |
| Total Liabilities And Equity | $405 | $405 | $353 | $428 | $443 |